Goldman Sachs trims Carl Zeiss Meditec voting rights to 5.39% from 5.58%PUBT·11 hours agoAFXGS-A-0.10%
Goldman Sachs lifts Carl Zeiss Meditec voting rights to 5.58% from 5.27%PUBT·1 day ago, 02:18 PMAFXGS-D+0.43%
Goldman Sachs lifts Carl Zeiss Meditec voting rights to 5.27% via instrumentsPUBT·2 days ago, 11:23 AMAFXGS-D+0.43%
Carl Zeiss Meditec adjusted EBITA falls 29.7% to €124.5 million in first nine months FY26; revenue drops 2.9% to €1.55 billionPUBT·Aug 6 at 05:00 AMAFX
J.P. Morgan Reaffirms Their Sell Rating on Carl Zeiss Meditec (0DHC)Tip Ranks·Jul 17 at 06:55 AMAFXRANK+0.95%
